Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9Z3V

Histidine-covalent 165G1 targeting hMcl-1

This is a non-PDB format compatible entry.
Replaces:  9CKN
Summary for 9Z3V
Entry DOI10.2210/pdb9z3v/pdb
DescriptorInduced myeloid leukemia cell differentiation protein Mcl-1, 165G1 (3 entities in total)
Functional Keywordshistidine-covalent stapled alpha-helical peptides, apoptosis
Biological sourceHomo sapiens (human)
More
Total number of polymer chains4
Total formula weight38730.21
Authors
Alboreggia, G.,Atienza, E.,Muzzarelli, K.M.,Assar, Z.,Pellecchia, M. (deposition date: 2025-11-07, release date: 2026-05-13, Last modification date: 2026-05-27)
Primary citationAlboreggia, G.,Atienza, E.L.,Muzzarelli, K.,Assar, Z.,Pellecchia, M.
Covalent Targeting of Histidine Residues: A Ligand-First Approach.
J.Med.Chem., 69:10201-10212, 2026
Cited by
PubMed Abstract: The design of irreversible drugs has resulted, over the past decade, in several new therapeutics in oncology that present improved pharmacodynamic and pharmaconetic properties compared to reversible ligands. Nevertheless, most ligands to date are designed to target a cysteine (Cys) residue, which is not a very common amino acid and only rarely occurs in protein target binding sites, thereby limiting the applicability of this covalent targeting approach. Recent work from our laboratory and others suggests that, after Cys, histidine (His) residues can be particularly suitable for covalent substitution with proper electrophiles. Using a ligand-first, structure-based approach, we assessed the possibility of using different electrophiles including acrylamides, chloroacetamides, or aryl fluorosulfates to target His residues covalently. Targeting His224 of hMcl-1 with model peptides, we demonstrate that both aryl fluorosulfates and chloroacetamides can be used to target His residues efficiently. Our studies also report strategies and biophysical approaches useful for the design and characterization of such His-covalent agents.
PubMed: 42054250
DOI: 10.1021/acs.jmedchem.5c03255
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.6 Å)
Structure validation

254917

PDB entries from 2026-06-10

PDB statisticsPDBj update infoContact PDBjnumon